Self Testing - Global Medical Devices Pipeline Assessment, 2019 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Nov 19, 2019--
The “Self Testing - Medical Devices Pipeline Assessment, 2019” report has been added to ResearchAndMarkets.com’s offering.
This report provides an overview of Self Testing currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development.
It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and the number of trials for the key Self Testing pipeline products.
- Extensive coverage of the Self Testing under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Self Testing and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Self Testing under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Key Topics Covered
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2.1 Self Testing Overview
3 Products under Development
3.1 Self Testing - Pipeline Products by Stage of Development
3.2 Self Testing - Pipeline Products by Territory
3.3 Self Testing - Pipeline Products by Regulatory Path
3.4 Self Testing - Pipeline Products by Estimated Approval Date
3.5 Self Testing - Ongoing Clinical Trials
4 Self Testing - Pipeline Products under Development by Companies
4.1 Self Testing Companies - Pipeline Products by Stage of Development
4.2 Self Testing - Pipeline Products by Stage of Development
5 Self Testing Companies and Product Overview
- Company Overview
- Pipeline Products & Ongoing Clinical Trials Overview
5.1 Atomo Diagnostics Pty. Ltd.
5.2 bioLytical Laboratories Inc.
5.3 Boston Microfluidics
5.4 Brigham & Women’s Hospital
5.5 Emory University
5.6 Entia Ltd.
5.7 InnaMed Inc.
5.8 Morgan Innovation & Technology Ltd.
5.9 Novosanis N.V.
5.11 Premier Medical Corporation
5.12 Shanghai Kehua Bio-engineering Co. Ltd.
5.13 Svenska Cellulosa Aktiebolaget
5.14 Tasso, Inc.
5.15 Wellmetrix LLC
6 Self Testing - Recent Developments
6.1 Sep 10, 2019: EKF Diagnostics Holdings: Half-year Report
6.2 Aug 19, 2019: Retirement of Dr. Sandra Horning & Appointment of Dr. Levi Garraway to Chief Medical Officer, Roche and Genentech
6.3 Aug 12, 2019: Biocept reports second quarter 2019 financial results
6.4 Jul 25, 2019: Roche reports very strong performance in the first half of 2019 - Outlook raised
6.5 Jul 15, 2019: EKF Diagnostics Holdings: Trading update
6.6 Jul 09, 2019: Mylan HIV Self Test receives WHO prequalification approval
6.7 Jun 14, 2019: Klobuchar, Murkowski introduce Legislation to Protect Consumers’ Private Health Data
6.8 Jun 11, 2019: Changes in Roche’s board of directors and corporate executive committee
6.9 Jun 11, 2019: Regulators demand more details on Roche’s $4.8bn Spark acquisition
6.10 May 08, 2019: Biocept reports first quarter 2019 financial results
6.11 Apr 25, 2019: Regarding the establishment of the new EIKEN ROAD MAP 2019 management framework and the new medium-term management plan
6.12 Apr 25, 2019: Eiken Chemical announced its financial results for the fiscal year ended March 31, 2019
6.13 Apr 17, 2019: Roche reports a strong start in 2019 and raises the outlook for the full-year
6.14 Apr 04, 2019: First HIV self-test approved for sale in Australia now available from Atomo Diagnostics
6.15 Mar 28, 2019: Biocept reports 2018 fourth quarter and full year financial results
6.16 Mar 21, 2019: Roche sues U.S. executives in fight over diabetes test strips
6.17 Mar 13, 2019: EKF Diagnostics Holdings: Final results
6.18 Feb 27, 2019: Biocept and Providence Saint John’s Health Center collaborate to evaluate cerebrospinal fluid for use with liquid biopsy testing in metastatic cancer
6.19 Jan 31, 2019: Roche reports very strong results in 2018
6.20 Jan 24, 2019: Genentech announces Alexander Hardy as Chief Executive Officer
6.21 Jan 11, 2019: Shimadzu’s new preparative purification LC System provides high efficiency, saves space, and enables multi-sample processing
6.22 Jan 07, 2019: MES to launch the first YO Home Sperm Test for PCs with personalized YO SCORE
6.23 Jan 02, 2019: Roche Diabetes Care India appoints Dr. Gaurav Laroia as general manager
6.24 Dec 13, 2018: Devicare announces the positive results of the clinical trial with Lit-Control to prevent the encrustation of catheters in patients with lithiasis
6.25 Dec 11, 2018: Brigham researchers develop smartphone-based Ovulation Test
6.26 Dec 10, 2018: New member proposed for election to Roche Board of Directors
6.27 Dec 10, 2018: Roche names William Bill Anderson as CEO from January 01 2019
6.28 Dec 03, 2018: Roche to increase its payroll in Switzerland by 1.2 percent
6.29 Nov 30, 2018: European Patent granted for Colli-Pee
6.30 Nov 29, 2018: Australian TGA approves Atomo HIV Self Test as first rapid diagnostic test for home use
6.31 Nov 28, 2018: INSTI HIV Self Test earns WHO prequalification status for home testing
6.32 Nov 08, 2018: Colli-Pee approved by Mexican Health Authority
6.33 Oct 31, 2018: Biocept announces new executive hires to its sales and marketing organization
6.34 Oct 25, 2018: Exeltis Spain launches the world’s first ever digital urology solution
For more information about this report visit https://www.researchandmarkets.com/r/f21jjl
View source version on businesswire.com:https://www.businesswire.com/news/home/20191119005812/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: MEDICAL DEVICES HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 11/19/2019 11:14 AM/DISC: 11/19/2019 11:14 AM